{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:01:22Z","timestamp":1791907282970,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sigrid Juselius Foundation and Academy of Finland","award":["Kuopio University Hospital VTR Fund"],"award-info":[{"award-number":["Kuopio University Hospital VTR Fund"]}]},{"name":"Italian Ministry of Health","award":["\"Ricerca corrente\""],"award-info":[{"award-number":["\"Ricerca corrente\""]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Idiopathic normal pressure hydrocephalus (iNPH) is a clinico-radiological syndrome of elderly individuals likely sustained by different neurodegenerative changes as copathologies. Since iNPH is a potentially reversible condition, assessing neurodegenerative pathologies in vitam through CSF biomarkers and their influence on clinical features and surgical outcome represents crucial steps.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We measured \u03b1-synuclein seeding activity related to Lewy body (LB) pathology by the real-time quaking-induced conversion assay (RT-QuIC) and Alzheimer disease core biomarkers (proteins total-tau, phospho-tau, and amyloid-beta) by immunoassays in the cerebrospinal fluid (CSF) of 293 iNPH patients from two independent cohorts. To compare the prevalence of LB copathology between iNPH participants and a control group representative of the general population, we searched for \u03b1-synuclein seeding activity in 89 age-matched individuals who died of Creutzfeldt-Jakob disease (CJD). Finally, in one of the iNPH cohorts, we also measured the CSF levels of neurofilament light chain protein (NfL) and evaluated the association between all CSF biomarkers, baseline clinical features, and surgery outcome at 6\u00a0months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Sixty (20.5%) iNPH patients showed \u03b1-synuclein seeding activity with no significant difference between cohorts. In contrast, the prevalence observed in CJD was only 6.7% (p\u2009=\u20090.002). Overall, 24.0% of iNPH participants showed an amyloid-positive (A+) status, indicating a brain co-pathology related to A\u03b2 deposition. At baseline, in the Italian cohort, \u03b1-synuclein RT-QuIC positivity was associated with higher scores on axial and upper limb rigidity (p\u2009=\u20090.003 and p\u2009=\u20090.011, respectively) and lower MMSEc scores (p\u2009=\u20090.003). A+\u2009patients showed lower scores on the MMSEc (p\u2009=\u20090.037) than A- patients. Higher NfL levels were also associated with lower scores on the MMSEc (rho\u2009=\u2009-0.213; p\u2009=\u20090.021). There were no significant associations between CSF biomarkers and surgical outcome at 6\u00a0months (i.e. responders defined by decrease of 1 point on the mRankin scale)<jats:bold>.<\/jats:bold><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Prevalent LB- and AD-related neurodegenerative pathologies affect a significant proportion of iNPH patients and contribute to cognitive decline (both) and motor impairment (only LB pathology) but do not significantly influence the surgical outcome at 6\u00a0months. Their effect on the clinical benefit after surgery over a more extended period remains to be determined.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12987-022-00368-2","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T14:02:42Z","timestamp":1662559362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome"],"prefix":"10.1186","volume":"19","author":[{"given":"Giulia","family":"Giannini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Baiardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Dellavalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Zenesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Cevoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Danner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna-Kaisa","family":"Jyrkk\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Polischi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Quadalti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Cortelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Milletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna-Kaisa","family":"Herukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Palandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"issue":"4","key":"368_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0022-510x(65)90016-x","volume":"2","author":"S Hakim","year":"1965","unstructured":"Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci. 1965;2(4):307\u201327. https:\/\/doi.org\/10.1016\/0022-510x(65)90016-x.","journal-title":"J Neurol Sci"},{"issue":"3","key":"368_CR2","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1227\/01.neu.0000168185.29659.c5","volume":"57","author":"N Relkin","year":"2005","unstructured":"Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005;57(3):S4-16. https:\/\/doi.org\/10.1227\/01.neu.0000168185.29659.c5.","journal-title":"Neurosurgery"},{"issue":"10","key":"368_CR3","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00701-013-1835-5","volume":"155","author":"AK Toma","year":"2013","unstructured":"Toma AK, Papadopoulos MC, Stapleton S, Kitchen ND, Watkins LD. Systematic review of the outcome of shunt surgery in idiopathic normal-pressure hydrocephalus. Acta Neurochir (Wien). 2013;155(10):1977\u201380. https:\/\/doi.org\/10.1007\/s00701-013-1835-5.","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"368_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ana.25046","volume":"82","author":"AJ Espay","year":"2017","unstructured":"Espay AJ, Da Prat GA, Dwivedi AK, Rodriguez-Porcel F, Vaughan JE, Rosso M, et al. Deconstructing normal pressure hydrocephalus: ventriculomegaly as early sign of neurodegeneration. Ann Neurol. 2017;82(4):503\u201313. https:\/\/doi.org\/10.1002\/ana.25046.","journal-title":"Ann Neurol"},{"issue":"16","key":"368_CR5","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000000342","volume":"82","author":"D Jaraj","year":"2014","unstructured":"Jaraj D, Rabiei K, Marlow T, Jensen C, Skoog I, Wikkels\u00f8 C. Prevalence of idiopathic normal-pressure hydrocephalus. Neurology. 2014;82(16):1449\u201354. https:\/\/doi.org\/10.1212\/WNL.0000000000000342.","journal-title":"Neurology"},{"issue":"2","key":"368_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3233\/JAD-181012","volume":"68","author":"S Abu-Rumeileh","year":"2019","unstructured":"Abu-Rumeileh S, Giannini G, Polischi B, Albini-Riccioli L, Milletti D, Oppi F, et al. Revisiting the cerebrospinal fluid biomarker profile in idiopathic normal pressure hydrocephalus: the bologna pro-hydro study. J Alzheimers Dis. 2019;68(2):723\u201333. https:\/\/doi.org\/10.3233\/JAD-181012.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"368_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12987-022-00306-2","volume":"19","author":"M Braun","year":"2022","unstructured":"Braun M, Bjurnemark C, Seo W, Freyhult E, Nyholm D, Niemel\u00e4 V, et al. Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus. Fluids Barriers CNS. 2022;19(1):15. https:\/\/doi.org\/10.1186\/s12987-022-00306-2.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"368_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12987-022-00309-z","volume":"19","author":"H Lukkarinen","year":"2022","unstructured":"Lukkarinen H, Jeppsson A, Wikkels\u00f6 C, Blennow K, Zetterberg H, Constantinescu R, et al. Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients. Fluids Barriers CNS. 2022;19(1):11. https:\/\/doi.org\/10.1186\/s12987-022-00309-z.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"368_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman BR, Orr\u00f9 CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B, et al. Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC. Acta Neuropathol Commun. 2018;6(1):7. https:\/\/doi.org\/10.1186\/s40478-018-0508-2.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"368_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orr\u00f9 CD, et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 2020;140(1):49\u201362. https:\/\/doi.org\/10.1007\/s00401-020-02160-8.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"368_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s40478-020-00990-x","volume":"8","author":"N Candelise","year":"2020","unstructured":"Candelise N, Baiardi S, Franceschini A, Rossi M, Parchi P. Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids. Acta Neuropathol Commun. 2020;8(1):117. https:\/\/doi.org\/10.1186\/s40478-020-00990-x.","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"368_CR12","doi-asserted-by":"publisher","first-page":"e930","DOI":"10.1212\/WNL.0000000000012438","volume":"97","author":"M Rossi","year":"2021","unstructured":"Rossi M, Baiardi S, Teunissen CE, Quadalti C, van de Beek M, Mammana A, et al. Diagnostic value of the CSF \u03b1-synuclein real-time quaking-induced conversion assay at the prodromal MCI stage of dementia with Lewy bodies. Neurology. 2021;97(9):e930\u201340. https:\/\/doi.org\/10.1212\/WNL.0000000000012438.","journal-title":"Neurology"},{"issue":"5","key":"368_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-0404.2007.00890.x","volume":"116","author":"A Agren-Wilsson","year":"2007","unstructured":"Agren-Wilsson A, Lekman A, Sj\u00f6berg W, Rosengren L, Blennow K, Bergenheim AT, et al. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand. 2007;116(5):333\u20139. https:\/\/doi.org\/10.1111\/j.1600-0404.2007.00890.x.","journal-title":"Acta Neurol Scand"},{"key":"368_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1743-8454-5-9","volume":"5","author":"M Tullberg","year":"2008","unstructured":"Tullberg M, Blennow K, M\u00e5nsson JE, Fredman P, Tisell M, Wikkels\u00f6 C. Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus. Cerebrospinal Fluid Res. 2008;5:9. https:\/\/doi.org\/10.1186\/1743-8454-5-9.","journal-title":"Cerebrospinal Fluid Res"},{"key":"368_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.parkreldis.2019.07.021","volume":"66","author":"G Giannini","year":"2019","unstructured":"Giannini G, Palandri G, Ferrari A, Oppi F, Milletti D, Albini-Riccioli L, et al. A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study. Parkinsonism Relat Disord. 2019;66:117\u201324. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.07.021.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"368_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12987-019-0142-9","volume":"16","author":"A Junkkari","year":"2019","unstructured":"Junkkari A, Luikku AJ, Danner N, Jyrkk\u00e4nen HK, Rauramaa T, Korhonen VE, et al. The Kuopio idiopathic normal pressure hydrocephalus protocol: initial outcome of 175 patients. Fluids Barriers CNS. 2019;16(1):21. https:\/\/doi.org\/10.1186\/s12987-019-0142-9.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"368_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.21198","volume":"22","author":"CG Goetz","year":"2007","unstructured":"Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, et al. Movement disorder society-sponsored revision of the unified parkinson\u2019s disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord. 2007;22(1):41\u20137. https:\/\/doi.org\/10.1002\/mds.21198.","journal-title":"Mov Disord"},{"issue":"2","key":"368_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S. The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142\u20138. https:\/\/doi.org\/10.1111\/j.1532-5415.1991.tb01616.x.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"368_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000111149","volume":"25","author":"Y Kubo","year":"2008","unstructured":"Kubo Y, Kazui H, Yoshida T, Kito Y, Kimura N, Tokunaga H, et al. Validation of grading scale for evaluating symptoms of idiopathic normal-pressure hydrocephalus. Dement Geriatr Cogn Disord. 2008;25(1):37\u201345. https:\/\/doi.org\/10.1159\/000111149.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"368_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0002-9343(86)90717-5","volume":"80","author":"ME Tinetti","year":"1986","unstructured":"Tinetti ME, Williams TF, Mayewski R. Fall risk index for elderly patients based on number of chronic disabilities. Am J Med. 1986;80(3):429\u201334. https:\/\/doi.org\/10.1016\/0002-9343(86)90717-5.","journal-title":"Am J Med"},{"issue":"12","key":"368_CR21","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1161\/01.str.19.12.1497","volume":"19","author":"R Bonita","year":"1988","unstructured":"Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988;19(12):1497\u2013500. https:\/\/doi.org\/10.1161\/01.str.19.12.1497.","journal-title":"Stroke"},{"issue":"2","key":"368_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1 5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351\u20136. https:\/\/doi.org\/10.2214\/ajr.149.2.351.","journal-title":"AJR Am J Roentgenol."},{"issue":"6","key":"368_CR23","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.str.32.6.1318","volume":"32","author":"LO Wahlund","year":"2001","unstructured":"Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sj\u00f6gren M, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32(6):1318\u201322. https:\/\/doi.org\/10.1161\/01.str.32.6.1318.","journal-title":"Stroke"},{"issue":"3","key":"368_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","volume":"20","author":"P Hermann","year":"2021","unstructured":"Hermann P, Appleby B, Brandel JP, Caughey B, Collins S, Geschwind MD, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021;20(3):235\u201346. https:\/\/doi.org\/10.1016\/S1474-4422(20)30477-4.","journal-title":"Lancet Neurol"},{"issue":"1","key":"368_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058.","journal-title":"Neurology"},{"issue":"2","key":"368_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/acn3.697","volume":"6","author":"S Baiardi","year":"2018","unstructured":"Baiardi S, Abu-Rumeileh S, Rossi M, Zenesini C, Bartoletti-Stella A, Polischi B, et al. Antemortem CSF A\u03b242\/A\u03b240 ratio predicts Alzheimer\u2019s disease pathology better than A\u03b242 in rapidly progressive dementias. Ann Clin Transl Neurol. 2018;6(2):263\u201373. https:\/\/doi.org\/10.1002\/acn3.697.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"368_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","volume":"10","author":"S Abu-Rumeileh","year":"2018","unstructured":"Abu-Rumeileh S, Capellari S, Stanzani-Maserati M, Polischi B, Martinelli P, Caroppo P, et al. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Alzheimers Res Ther. 2018;10(1):3. https:\/\/doi.org\/10.1186\/s13195-017-0331-1.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"368_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/jcm10051105","volume":"10","author":"A Vanninen","year":"2021","unstructured":"Vanninen A, Nakajima M, Miyajima M, Rauramaa T, Kokki M, Musialowicz T, et al. Elevated CSF LRG and decreased Alzheimer\u2019s disease biomarkers in idiopathic normal pressure hydrocephalus. J Clin Med. 2021;10(5):1105. https:\/\/doi.org\/10.3390\/jcm10051105.","journal-title":"J Clin Med"},{"issue":"6","key":"368_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745\u201352. https:\/\/doi.org\/10.1136\/jnnp.51.6.745.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"368_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.0305-1846.2001.00342.x","volume":"27","author":"L Parkkinen","year":"2001","unstructured":"Parkkinen L, Soininen H, Laakso M, Alafuzoff I. Alpha-synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol. 2001;27(4):314\u201325. https:\/\/doi.org\/10.1046\/j.0305-1846.2001.00342.x.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"368_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"368_CR32","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1212\/01.wnl.0000204179.88955.fa","volume":"66","author":"KJ Klos","year":"2006","unstructured":"Klos KJ, Ahlskog JE, Josephs KA, Apaydin H, Parisi JE, Boeve BF, et al. Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology. 2006;66(7):1100\u20132. https:\/\/doi.org\/10.1212\/01.wnl.0000204179.88955.fa.","journal-title":"Neurology"},{"key":"368_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120019","volume":"433","author":"J Youn","year":"2022","unstructured":"Youn J, Todisco M, Zappia M, Pacchetti C, Fasano A. Parkinsonism and cerebrospinal fluid disorders. J Neurol Sci. 2022;433: 120019. https:\/\/doi.org\/10.1016\/j.jns.2021.120019.","journal-title":"J Neurol Sci"},{"issue":"4","key":"368_CR34","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1007\/s00415-021-10778-1","volume":"269","author":"A Sakurai","year":"2022","unstructured":"Sakurai A, Tsunemi T, Ishiguro Y, Okuzumi A, Hatano T, Hattori N. Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus. J Neurol. 2022;269(4):2022\u20139. https:\/\/doi.org\/10.1007\/s00415-021-10778-1.","journal-title":"J Neurol"},{"issue":"10","key":"368_CR35","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s00415-017-8598-5","volume":"264","author":"K Molde","year":"2017","unstructured":"Molde K, S\u00f6derstr\u00f6m L, Laurell K. Parkinsonian symptoms in normal pressure hydrocephalus: a population-based study. J Neurol. 2017;264(10):2141\u20138. https:\/\/doi.org\/10.1007\/s00415-017-8598-5.","journal-title":"J Neurol"},{"key":"368_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.wneu.2016.03.004","volume":"90","author":"M Broggi","year":"2016","unstructured":"Broggi M, Redaelli V, Tringali G, Restelli F, Romito L, Schiavolin S, et al. Normal pressure hydrocephalus and Parkinsonism: preliminary data on neurosurgical and neurological treatment. World Neurosurg. 2016;90:348\u201356. https:\/\/doi.org\/10.1016\/j.wneu.2016.03.004.","journal-title":"World Neurosurg"},{"issue":"10","key":"368_CR37","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1007\/s00415-018-9029-y","volume":"265","author":"G Allali","year":"2018","unstructured":"Allali G, Garibotto V, Mainta IC, Nicastro N, Assal F. Dopaminergic imaging separates normal pressure hydrocephalus from its mimics. J Neurol. 2018;265(10):2434\u201341. https:\/\/doi.org\/10.1007\/s00415-018-9029-y.","journal-title":"J Neurol"},{"issue":"1","key":"368_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/mds.28366","volume":"36","author":"NG Pozzi","year":"2021","unstructured":"Pozzi NG, Brumberg J, Todisco M, Minafra B, Zangaglia R, Bossert I, et al. Striatal dopamine deficit and motor impairment in idiopathic normal pressure hydrocephalus. Mov Disord. 2021;36(1):124\u201332. https:\/\/doi.org\/10.1002\/mds.28366.","journal-title":"Mov Disord"},{"issue":"5","key":"368_CR39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jalz.2010.12.008","volume":"7","author":"D Cabral","year":"2011","unstructured":"Cabral D, Beach TG, Vedders L, Sue LI, Jacobson S, Myers K, et al. Frequency of Alzheimer\u2019s disease pathology at autopsy in patients with clinical normal pressure hydrocephalus. Alzheimers Dement. 2011;7(5):509\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2010.12.008.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"368_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1365-2990.2011.01195.x","volume":"38","author":"V Leinonen","year":"2012","unstructured":"Leinonen V, Koivisto AM, Savolainen S, Rummukainen J, Sutela A, Vanninen R, et al. Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature. Neuropathol Appl Neurobiol. 2012;38(1):72\u201386. https:\/\/doi.org\/10.1111\/j.1365-2990.2011.01195.x.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"368_CR41","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1212\/wnl.50.4.1122","volume":"50","author":"M Tullberg","year":"1998","unstructured":"Tullberg M, Rosengren L, Blomsterwall E, Karlsson JE, Wikkels\u00f6 C. CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology. 1998;50(4):1122\u20137. https:\/\/doi.org\/10.1212\/wnl.50.4.1122.","journal-title":"Neurology"},{"issue":"12","key":"368_CR42","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00701-017-3314-x","volume":"159","author":"CL Craven","year":"2017","unstructured":"Craven CL, Baudracco I, Zetterberg H, Lunn MPT, Chapman MD, Lakdawala N, et al. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien). 2017;159(12):2293\u2013300. https:\/\/doi.org\/10.1007\/s00701-017-3314-x.","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"368_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2017.7.JNS171005","volume":"130","author":"S Abu Hamdeh","year":"2018","unstructured":"Abu Hamdeh S, Virhammar J, Sehlin D, Alafuzoff I, Cesarini KG, Marklund N. Brain tissue A\u03b242 levels are linked to shunt response in idiopathic normal pressure hydrocephalus. J Neurosurg. 2018;130(1):121\u20139. https:\/\/doi.org\/10.3171\/2017.7.JNS171005.","journal-title":"J Neurosurg"},{"key":"368_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-022-05154-5","author":"SG Thavarajasingam","year":"2022","unstructured":"Thavarajasingam SG, El-Khatib M, Vemulapalli KV, Iradukunda HAS, Laleye J, Russo S, et al. Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. Acta Neurochir (Wien). 2022. https:\/\/doi.org\/10.1007\/s00701-022-05154-5.","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"368_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-0404.2012.01677.x","volume":"126","author":"P Hellstr\u00f6m","year":"2012","unstructured":"Hellstr\u00f6m P, Klinge P, Tans J, Wikkels\u00f8 C. A new scale for assessment of severity and outcome in iNPH. Acta Neurol Scand. 2012;126(4):229\u201337. https:\/\/doi.org\/10.1111\/j.1600-0404.2012.01677.x.","journal-title":"Acta Neurol Scand"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-022-00368-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T02:04:33Z","timestamp":1662602673000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-022-00368-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1186\/s12987-022-00368-2","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"6 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in agreement with the principles of good clinical practice and the Helsinki Declaration. The Bologna PRO-HYDRO study protocol was approved by the Local Ethics Committee (Code: 14131, 23\/02\/2015). Permission for the Kuopio idiopathic normal pressure hydrocephalus protocol was received from the Research Ethics Board of KUH (Hospital District of Northern Savo, Kuopio, Finland). All patients gave their written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GG reports no disclosures. SB reports no disclosures. SD reports no disclosures. CZ reports no disclosures. SC reports no disclosures. ND reports no disclosures. HKJ reports no disclosures. MR reports no disclosures. BP reports no disclosures. CQ reports no disclosures. CS reports no disclosures. PC reports no disclosures. DM reports no disclosures. SKH reports no disclosures. GP reports no disclosures. VL reports no disclosers. PP reports no disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}